Iboga wellness is not spa wellness. The word describes a category of outcomes — reduced addiction severity, reduced PTSD, improved emotional baseline — that iboga produces through neurological mechanisms, not through relaxation or retreat aesthetics. The active ceremony lasts 12–24 hours and involves systematic access to autobiographical memory. Most people describe it as more like watching a documentary about their own life than anything resembling a wellness experience in the conventional sense.
The 2023 Stanford study published in Nature Medicine found 88% reductions in PTSD symptoms, 87% in depression, and 81% in anxiety at one month in 30 special operations veterans with treatment-resistant conditions. Those outcomes were produced through a single ceremony. Whether they become lasting depends entirely on what happens after. The iboga wellness outcomes most people are looking for are real. The path to them is specific, and it is not for everyone.

What Iboga Wellness Actually Produces
Ibogaine, the primary psychoactive alkaloid in Tabernanthe ibogaroot bark, acts on multiple receptor systems simultaneously — sigma-2, NMDA, opioid mu-delta-kappa, and serotonin transporters. The net effect is a neurological intervention unlike anything produced by conventional psychiatric medication.
The most rigorous evidence comes from the 2023 Stanford study published in Nature Medicine. The population was 30 special operations veterans with PTSD, traumatic brain injury, and treatment-resistant depression — people who had already gone through conventional treatment without adequate results. At one month post-ceremony:
- PTSD symptoms: 88% average reduction
- Depression symptoms: 87% average reduction
- Anxiety symptoms: 81% average reduction
For context, conventional antidepressant research considers a 50% reduction in depression scores a “strong response.” The Stanford numbers are not in the same category as what is typically described as pharmaceutical progress.
The study has real limitations. 30 veterans is not a definitive population. There was no placebo arm. These caveats are genuine — and the numbers are compelling enough to stand with them included. The $50 million committed to follow-up clinical trials at UTMB, UTHealth Houston, Texas A&M, and Baylor University suggests institutional medicine has read the results the same way.
How Iboga Affects the Brain
The active ceremony phase lasts 12–24 hours. What most people describe is not visual or sensory in the psychedelic sense — it is autobiographical. Specific memories, patterns, and the emotional logic that connects them become available in an unusually direct way. This is not a comfortable process. The medicine does not spare the difficult content. People who arrive expecting iboga to deliver positive experiences are misunderstanding what it does.
After the active phase, the metabolite noribogaine remains biologically active for weeks to months. During that window, craving is measurably reduced, emotional reactivity stabilises, and the brain's capacity for new learning appears heightened. This is the window that produces — or fails to produce — lasting change.
The primary driver of longer-term effect is GDNF upregulation. Glial cell line-derived neurotrophic factor supports neuronal survival and repair. Chronic substance use depletes it. Ibogaine reverses that depletion at a level no currently approved medication approaches. BDNF (brain-derived neurotrophic factor) elevation also occurs, overlapping with mechanisms shared by antidepressants — but the magnitude and timeline differ substantially.
The medical requirements follow directly from the pharmacology. Ibogaine prolongs the cardiac QT interval during the active experience. In people with specific pre-existing conditions, this creates real arrhythmia risk. An EKG before ceremony is not a bureaucratic step — it is how you identify those conditions before ceremony, not during it. Any provider operating without this screening is not operating safely.

What Iboga Cannot Do
Iboga is not a cure for addiction. The Stanford study was not a cure study — it measured symptom reduction at one month in a specific population. That reduction is real. What converts it into lasting change is entirely dependent on what happens after the ceremony window closes.
Iboga does not override environment. A person who returns immediately to the same relationships, the same living situation, and the same unaddressed conditions that produced the problem is not being helped by the ceremony. They are being given a period of reduced symptom burden in a context that remains fundamentally unchanged. Whether they use that advantage is not a function of how well the medicine worked — it is a function of what they do with what the medicine showed them.
The contrast between what was available during the noribogaine window and what was lost by not making structural use of it is, in our experience, one of the sharper forms of suffering this work can produce. The ceremony was profound. The person left with clarity and reduced craving. Six weeks later they were back where they had started — or somewhere harder, because the gap between what was possible and what they had returned to was now visible. This happens when people return to unchanged conditions with no integration support in place. The window does not stay open indefinitely. What is done in that window determines the outcome.
Integration support is not a bonus service. It determines whether the ceremony produces lasting change. The ceremony opens the window. Integration is the work done while it is open. Providers who hand people a summary document and wish them well are not providing iboga wellness — they are providing iboga.
Who Is Not a Candidate
Not everyone who applies is an appropriate candidate for iboga ceremony. A meaningful proportion of people who reach out are not, at the time of first contact, people for whom this medicine can be administered safely. This is told to them directly, without softening it.
Absolute contraindications — conditions that make iboga ceremony genuinely dangerous:
- QT prolongation or significant cardiac arrhythmia. The EKG determines this before ceremony. Some cardiac presentations can be managed with additional precautions. Others are absolute disqualifiers. The EKG is how you find out which you are looking at before ceremony, not during it.
- Current SSRIs or SNRIs.This is not a preference — it is a contraindication. The risk of serotonin syndrome when ibogaine is administered to someone still carrying SSRI medication load is real and potentially fatal. A supervised taper to zero is required. The minimum timeline is typically 2–4 weeks, often longer depending on the specific medication and duration of use. No exceptions.
- Methadone. A specific transition protocol is required. The timeline is longer than most people expect. Simple cessation before ibogaine is not safe.
- Severe liver or kidney disease. Ibogaine is metabolised through the liver. Impaired function changes the pharmacokinetics in ways that increase risk.
- Active psychosis or schizophrenia-spectrum disorder. Ibogaine is not appropriate for these presentations.
- Lithium. An absolute contraindication due to seizure risk.
- Pregnancy.
- Acute psychiatric crisis. Someone in acute crisis is not an appropriate candidate at that moment regardless of how urgently they want access. The experience amplifies what is already present. Entering it in a state of acute psychiatric instability does not produce stability.
If any of these apply, the answer is not how to proceed anyway. For SSRIs, the taper is the first step — it takes time, and the timeline matters. For cardiac conditions, it depends on what the EKG shows. For methadone, there is a protocol, but it cannot be rushed. We tell people this directly. The people who don't want to hear it are sometimes the people for whom it matters most.
There is also a category of people who should not pursue iboga for the wrong reasons. If you are primarily seeking a mystical experience, a shortcut to insight, or a way of feeling something without sustained change, this medicine will disappoint you. It is appropriate for people who have been doing the work and are stuck — not for people who want to skip it.
The Integration Period — Where Outcomes Actually Happen
In Bwiti tradition, the ceremony is embedded in an ongoing community structure. There is a framework for understanding what arises, and ongoing relationships that hold the work beyond the active experience. In a contemporary North American context, that structure does not exist automatically. It has to be built deliberately before the ceremony begins.
Integration coaching — $150–$300 CAD per session, with packages of three or more available — is the structured work done during the noribogaine window. This is not therapy in the conventional sense. It is work oriented toward specific behavioural and environmental changes: the ones the ceremony identified as necessary. It covers how to use what was seen, what structural changes are required in the person's actual life, and how to manage the unusual openness the medicine produces before normal patterns reinstate themselves.
Most people who make lasting use of what iboga shows them have this support in place before they leave Vancouver. The people who arrive at ceremony having already thought seriously about what they are going to do with the window that follows are not being overly cautious. They are being realistic about how the medicine works.
Read more about what integration coaching at Transcend involves and how it fits into a complete programme.
Is This Right for You?
The ceremony page covers what the iboga experience involves in detail — the three phases, what to expect physically and psychologically, and what the 2–3 day recovery period looks like. The FAQ answers the most common questions about screening, cost, and what a week in Vancouver actually involves.
The ibogaine for depression article covers the GDNF-BDNF mechanism in more depth. The iboga treatment centre guide explains what to look for when evaluating a provider — including the clinical infrastructure that separates a legitimate programme from a marketing exercise.
If you are trying to determine whether you are a candidate before making any commitments, the intake process is where that question is answered — not by reading this page. Apply through the form and you will receive a personal response within 2–3 business days. Every application is reviewed personally.
If you are not an appropriate candidate at this time, we will say so directly. We would rather lose a potential participant than confirm a ceremony date for someone the medicine cannot safely serve.
Further reading: Ibogaine for depression · Iboga treatment centres · Ibogaine treatment in Canada · Stanford ibogaine study (Nature Medicine, 2023) · Ibogaine safety review (Journal of Psychopharmacology, 2012)
Frequently Asked Questions
- What is iboga wellness?
- Iboga wellness refers to outcomes — reduction in PTSD, depression, anxiety, and addiction — produced by iboga ceremony through specific neurological mechanisms. It is not a wellness category in the spa or retreat sense. The active experience lasts 12–24 hours and involves direct confrontation with autobiographical content. The outcomes that follow depend on both the ceremony and the integration period that comes after.
- What conditions does iboga help with?
- The strongest evidence is for PTSD, treatment-resistant depression, and substance dependence. The 2023 Stanford study found 88% reductions in PTSD symptoms, 87% in depression, and 81% in anxiety at one month in 30 special operations veterans. Iboga is also used for opioid and alcohol dependence, where the GDNF-mediated neurological reset produces a measurable reduction in craving that conventional medications do not approach.
- How long do iboga wellness outcomes last?
- The noribogaine metabolite remains active for weeks to months after a single ceremony, producing a sustained window of reduced craving and increased neuroplasticity. How much of that window is converted into lasting change depends on what the person does during it. People with deliberate integration support in place consistently show better long-term outcomes than those who return to their prior environment without structure.
- What does an iboga wellness programme in Vancouver cost?
- Iboga ceremony at Transcend costs $2,000–$5,000 CAD. This covers an on-site medical professional throughout the 12–24 hour active ceremony, continuous cardiac monitoring, whole-plant root bark, full facilitation, and 2–3 days of supervised recovery. Integration coaching — the structured work done in the weeks after ceremony — is a separate service at $150–$300 CAD per session.
- Is iboga wellness safe?
- Ibogaine has documented cardiac risks — specifically QT interval prolongation during the active experience. For people without cardiac contraindications who have been properly screened, iboga ceremony conducted with an on-site physician and continuous cardiac monitoring has a strong safety record. For people with QT prolongation, significant arrhythmia, SSRIs, or certain other medications and conditions, it is not safe. This is why medical screening before any ceremony date is confirmed is not optional.
- Who is not appropriate for iboga wellness?
- Absolute contraindications include QT prolongation or significant cardiac arrhythmia, current SSRIs or SNRIs without a completed supervised taper (serotonin syndrome risk), methadone without a supervised transition protocol, lithium, active psychosis or schizophrenia-spectrum disorder, severe liver or kidney disease, and pregnancy. Acute psychiatric crisis is also a disqualifier at that time. These are not preferences — they are conditions under which ibogaine produces real risk.
- How is iboga different from other plant medicines for wellness?
- Iboga operates through narrative — a direct encounter with autobiographical content over 12–24 hours — and produces changes that persist through the noribogaine metabolite for weeks to months. Ayahuasca operates through shorter, more visionary experiences repeated across several sessions. 5-MeO-DMT produces 20–45 minutes of complete ego dissolution with no narrative content. These are not interchangeable. Each is appropriate for specific presentations and contraindicated in others. The ibogaine vs. ayahuasca comparison covers the differences in more depth.
- Where can I access iboga wellness in Canada?
- Iboga is not listed under Canada's Controlled Drugs and Substances Act, which allows Canadian providers to operate openly with full medical infrastructure. Vancouver, BC, is the primary access point for North Americans — a drivable distance for most of the Pacific Northwest, and a direct flight from most of North America. The critical question is not where a provider is located but what clinical infrastructure they maintain: mandatory EKG, on-site physician during ceremony, and continuous cardiac monitoring.